Loading...
Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer
PURPOSE: To determine the safety, dosing schedules, pharmacokinetic profile, and biologic effect of orally administered histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) in patients with advanced cancer. PATIENTS AND METHODS: Patients with solid and hematologic malignancies were t...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2005
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1855284/ https://ncbi.nlm.nih.gov/pubmed/15897550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2005.14.167 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|